Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression

Free Radical Biology and Medicine

Volumn 49, Issue 12, 2010, Pages 2078-2087

  Shan, Weihua ^a   Zhong, Weixiong ^a,b   Zhao, Rui ^c   Oberley, Terry D ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Androgen; Free radicals; Prostate cancer; Reactive oxygen species; Redox state; Thioredoxin 1

Indexed keywords

ANDROGEN; THIOREDOXIN 1;

ARTICLE; BENIGN TUMOR; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; MALE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIZATION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; WESTERN BLOTTING;

ADENOCARCINOMA; CELL DEATH; CELL LINE; CELL NUCLEUS; CYTOPLASM; HUMANS; LYMPHATIC METASTASIS; MALE; METRIBOLONE; OXIDATION-REDUCTION; PROSTATE; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; THIOREDOXIN-DISULFIDE REDUCTASE; THIOREDOXINS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 78650171625     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.10.691     Document Type: Article

References (28)

1. P.J. Halvey, W.H. Watson, J.M. Hansen, Y.M. Go, A. Samali, and D.P. Jones Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling Biochem. J. 386 2005 215 219
2. Y.M. Go, T.R. Ziegler, J.M. Johnson, L. Gu, J.M. Hansen, and D.P. Jones Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells Free Radic. Biol. Med. 42 2007 363 370
3. Y. Sun, and B. Rigas The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents Cancer Res. 68 2008 8269 8277
4. J.M. Hansen, Y.M. Go, and D.P. Jones Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling Annu. Rev. Pharmacol. Toxicol. 46 2006 215 234
5. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radic. Biol. Med. 30 2001 1191 1212
6. T. Hayashi, Y. Ueno, and T. Okamoto Oxidoreductive regulation of nuclear factor kappa B: involvement of a cellular reducing catalyst thioredoxin J. Biol. Chem. 268 1993 11380 11388
7. M. Ueno, H. Masutani, R.J. Arai, A. Yamauchi, K. Hirota, T. Sakai, T. Inamoto, Y. Yamaoka, J. Yodoi, and T. Nikaido Thioredoxin-dependent redox regulation of p53-mediated p21 activation J. Biol. Chem. 274 1999 35809 35815
8. J.M. Hansen, W.H. Watson, and D.P. Jones Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1 Toxicol. Sci. 82 2004 308 317
9. M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 EMBO J. 17 1998 2596 2606
10. A. Mukherjee, and S.G. Martin The thioredoxin system: a key target in tumour and endothelial cells Br. J. Radiol. 81 2008 S57 S68 Spec. No. 1
11. Y.M. Go, and D.P. Jones Redox control systems in the nucleus: mechanisms and functions Antioxid. Redox Signaling 13 2010 489 509
12. B. Kumar, S. Koul, L. Khandrika, R.B. Meacham, and H.K. Koul Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype Cancer Res. 68 2008 1777 1785
13. W.H. Watson, J. Pohl, W.R. Montfort, O. Stuchlik, M.S. Reed, G. Powis, and D.P. Jones Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif J. Biol. Chem. 278 2003 33408 33415
14. Y. Wang, G.W. De Keulenaer, and R.T. Lee Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin J. Biol. Chem. 277 2002 26496 26500
15. R. Zhao, N. Xiang, F.E. Domann, and W. Zhong Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells Cancer Res. 66 2006 2296 2304
16. L. Chaiswing, J.M. Bourdeau-Heller, W. Zhong, and T.D. Oberley Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness Free Radic. Biol. Med. 43 2007 202 215
17. R.E. Sobel, Y. Wang, and M.D. Sadar Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells In Vitro Cell. Dev. Biol. Anim. 42 2006 33 39
18. K.C. Das, Y. Lewis-Molock, and C.W. White Elevation of manganese superoxide dismutase gene expression by thioredoxin Am. J. Respir. Cell Mol. Biol. 17 1997 713 726
19. Y. Zhao, L. Chaiswing, J.M. Velez, I. Batinic-Haberle, N.H. Colburn, and T.D. Oberley St Clair, D. K. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase Cancer Res. 65 2005 3745 3750
20. Y. Zhao, L. Chaiswing, T.D. Oberley, I. Batinic-Haberle, W. St Clair, C.J. Epstein, and D. St Clair A mechanism-based antioxidant approach for the reduction of skin carcinogenesis Cancer Res. 65 2005 1401 1405
21. M.O. Ripple, W.F. Henry, R.P. Rago, and G. Wilding Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells J. Natl Cancer Inst. 89 1997 40 48
22. S.J. Kim, Y. Miyoshi, T. Taguchi, Y. Tamaki, H. Nakamura, J. Yodoi, K. Kato, and S. Noguchi High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer Clin. Cancer Res. 11 2005 8425 8430
23. M. Yamada, A. Tomida, H. Yoshikawa, Y. Taketani, and T. Tsuruo Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines Cancer Chemother. Pharmacol. 40 1997 31 37
24. A. Yokomizo, M. Ono, H. Nanri, Y. Makino, T. Ohga, M. Wada, T. Okamoto, J. Yodoi, M. Kuwano, and K. Kohno Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide Cancer Res. 55 1995 4293 4296
25. A. Mukherjee, A.D. Westwell, T.D. Bradshaw, M.F. Stevens, J. Carmichael, and S.G. Martin Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study Br. J. Cancer 92 2005 350 358
26. S. Le Jan, N. Le Meur, A. Cazes, J. Philippe, M. Le Cunff, J. Leger, P. Corvol, and S. Germain Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer FEBS Lett. 580 2006 3395 3400
27. M.K. Ng, J. Wu, E. Chang, B.Y. Wang, R. Katzenberg-Clark, A. Ishii-Watabe, and J.P. Cooke A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration Arterioscler. Thromb. Vasc. Biol. 27 2007 106 112
28. S.I. Hashemy, and A. Holmgren Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues J. Biol. Chem. 283 2008 21890 21898